Breathing Life into Innovation: How Patent Intelligence Accelerates Access to Asthma Care
On World Asthma Day 2026, the global call to action is clear: “Access to anti-inflammatory inhalers for everyone.”
While medical science has advanced rapidly—from the first metered-dose inhalers to today’s AI-driven “smart” devices—a critical gap remains. Millions of patients still lack access to life-saving treatments due to supply chain complexities, cost barriers, and the labyrinth of regulatory exclusivity.
At Saturo Global, we believe the path to accessible healthcare is paved with precise intelligence. Bridging the gap between a breakthrough molecule and a patient’s bedside requires navigating a dense forest of intellectual property (IP). This is where our expertise and our partnership with Minesoft become your strategic advantage.
The IP Challenge in Respiratory Care
Delivering affordable asthma care isn’t just a manufacturing challenge; it’s an IP puzzle. The “Purple Book” and “Orange Book” landscapes for respiratory biologics and device-drug combinations are notoriously complex.
- Generic manufacturers need absolute clarity on patent expiry dates to launch affordable alternatives the moment exclusivity ends.
- Innovators need to map “white spaces” in the crowded field of smart inhalers and connected delivery systems.
Powering Decisions with PatBase
As the authorized sales and service partner for Minesoft in India, Saturo Global empowers R&D teams and IP counsels with PatBase, the world’s most trusted global patent database.
Here is how PatBase transforms asthma research and access strategies:
- Accelerating Generic Entry: With integrated FDA Orange Book data and precise legal status trackers, PatBase allows users to pinpoint exact patent expiry dates for blockbuster inhalers, clearing the runway for affordable generics.
- Navigating “Smart” Innovation: The rise of digital health in asthma management has triggered a patent boom. PatBase’s Analytics V3 helps R&D teams visualize the landscape of connected devices, ensuring your new sensor-enabled inhaler doesn’t infringe on existing IP.
- Chemical Intelligence: Using TextMine, researchers can instantly extract and analyze chemical structures from millions of full-text documents, identifying novel formulations that could offer better stability or efficacy.
Saturo Global: Your Strategic Partner
Data alone is not enough. You need the insight to act on it.
Saturo Global combines the raw power of PatBase with our high-touch Patent Analytics and Search Services. Whether you are conducting a Freedom-to-Operate (FTO) search for a new dry powder inhaler or need a landscape report on biological treatments for severe asthma, our team transforms complex data into clear, actionable business intelligence.
Saturo Global combines the raw power of PatBase with our high-touch Patent Analytics and Search Services. Whether you are conducting a Freedom-to-Operate (FTO) search for a new dry powder inhaler or need a landscape report on biological treatments for severe asthma, our team transforms complex data into clear, actionable business intelligence.
Drive Innovation. Ensure Access.
This World Asthma Day, let’s commit to removing the barriers between innovation and the patients who need it. Whether you are protecting a new discovery or breaking down walls for generic access, the right intelligence makes all the difference.
Ready to clear the path for your next respiratory breakthrough?
Contact Saturo Global to discover how the right IP tools can secure your innovations and accelerate your time-to-market.
